Compare EOLS & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EOLS | LXFR |
|---|---|---|
| Founded | 2012 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.0M | 465.6M |
| IPO Year | 2018 | 2002 |
| Metric | EOLS | LXFR |
|---|---|---|
| Price | $7.61 | $17.26 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 669.0K | 337.9K |
| Earning Date | 11-04-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 3.01% |
| EPS Growth | ★ 1.23 | N/A |
| EPS | N/A | ★ 0.31 |
| Revenue | $297,176,000.00 | ★ $384,600,000.00 |
| Revenue This Year | $12.44 | N/A |
| Revenue Next Year | $17.37 | $6.26 |
| P/E Ratio | ★ N/A | $55.71 |
| Revenue Growth | ★ 11.61 | N/A |
| 52 Week Low | $3.86 | $11.26 |
| 52 Week High | $9.31 | $19.45 |
| Indicator | EOLS | LXFR |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 52.76 |
| Support Level | $7.59 | $17.19 |
| Resistance Level | $7.83 | $17.38 |
| Average True Range (ATR) | 0.32 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 79.57 | 58.33 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.